NYSTATIN\TRIAMCINOLONE ACETONIDE: 164 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
164
Total FAERS Reports
0
Deaths Reported
0
Hospitalizations
164
As Primary/Secondary Suspect
1
Disabilities
First Report: 2008 · Latest Report: 20240410
What Are the Most Common NYSTATIN\TRIAMCINOLONE ACETONIDE Side Effects?
#1 Most Reported
Drug ineffective
33 reports (20.1%)
#2 Most Reported
Product use in unapproved indication
22 reports (13.4%)
#3 Most Reported
Application site pain
14 reports (8.5%)
All NYSTATIN\TRIAMCINOLONE ACETONIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 33 | 20.1% | 0 | 0 |
| Product use in unapproved indication | 22 | 13.4% | 0 | 0 |
| Application site pain | 14 | 8.5% | 0 | 0 |
| Drug ineffective for unapproved indication | 11 | 6.7% | 0 | 0 |
| Expired product administered | 10 | 6.1% | 0 | 0 |
| Pruritus | 9 | 5.5% | 0 | 0 |
| Accidental exposure to product | 8 | 4.9% | 0 | 0 |
| Burning sensation | 8 | 4.9% | 0 | 0 |
| Condition aggravated | 8 | 4.9% | 0 | 0 |
| Insomnia | 8 | 4.9% | 0 | 0 |
| Wrong technique in product usage process | 8 | 4.9% | 0 | 0 |
| Drug effective for unapproved indication | 7 | 4.3% | 0 | 0 |
| Rash | 7 | 4.3% | 0 | 0 |
| Pain | 6 | 3.7% | 0 | 0 |
| Application site erythema | 5 | 3.1% | 0 | 0 |
| Application site irritation | 5 | 3.1% | 0 | 0 |
| Drug hypersensitivity | 5 | 3.1% | 0 | 0 |
| Inappropriate schedule of product administration | 5 | 3.1% | 0 | 0 |
| Off label use | 5 | 3.1% | 0 | 0 |
| Product container issue | 5 | 3.1% | 0 | 0 |
Who Reports NYSTATIN\TRIAMCINOLONE ACETONIDE Side Effects? Age & Gender Data
Gender: 69.0% female, 31.0% male. Average age: 62.3 years. Most reports from: US. View detailed demographics →
Is NYSTATIN\TRIAMCINOLONE ACETONIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 0 | 0 |
| 2011 | 1 | 0 | 0 |
| 2014 | 5 | 0 | 0 |
| 2015 | 12 | 0 | 0 |
| 2016 | 4 | 0 | 0 |
| 2017 | 5 | 0 | 0 |
| 2018 | 10 | 0 | 0 |
| 2019 | 7 | 0 | 0 |
| 2020 | 9 | 0 | 0 |
| 2021 | 5 | 0 | 0 |
| 2022 | 4 | 0 | 0 |
| 2023 | 3 | 0 | 0 |
| 2024 | 3 | 0 | 0 |
What Is NYSTATIN\TRIAMCINOLONE ACETONIDE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 35 |
| Fungal infection | 15 |
| Rash | 15 |
| Pruritus | 8 |
| Vulvovaginal pruritus | 7 |
| Candida infection | 5 |
| Fungal skin infection | 5 |
| Vulvovaginal mycotic infection | 5 |
NYSTATIN\TRIAMCINOLONE ACETONIDE vs Alternatives: Which Is Safer?
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OBETICHOLIC ACID
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OBINUTUZUMAB
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCELLA
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCRELIZUMAB
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCRIPLASMIN
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCTINOXATE\OCTISALATE\ZINC
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCTINOXATE\OCTOCRYLENE
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCTREOTIDE
NYSTATIN\TRIAMCINOLONE ACETONIDE vs OCTREOTIDE\OCTREOTIDE
NYSTATIN\TRIAMCINOLONE ACETONIDE vs ODEVIXIBAT
Official FDA Label for NYSTATIN\TRIAMCINOLONE ACETONIDE
Official prescribing information from the FDA-approved drug label.